volume 8, issue 3, Pe205-e215 2021
DOI: 10.1016/s2352-3026(20)30394-x
View full text
Comment 2021-3Has erratum 2021-6
|
|
Share

Abstract: Background Diagnosis and remission status at the time of allogeneic haematopoietic stem-cell transplantation (HSCT) are the principal determinants of overall survival following transplantation. We sought to develop a contemporary disease-risk stratification system (DRSS) that accounts for heterogeneous transplantation indications.Methods In this retrospective cohort study we included 55 histology and remission status combinations across haematological malignancies, including acute leukaemia, lymphoma, multiple…

Expand abstract
Editorial notices

Search citation statements

Order By: Relevance

Paper Sections

0
0
0
0
0

Citation Types

0
1
0

Publication Types

Select...

Relationship

0
0

Authors

Journals